Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Receivables - Net (2021 - 2026)

Zymeworks (ZYME) posted Receivables - Net of $4.7 million for Q1 2026, up 0.78% sequentially from $4.6 million in Q4 2025, and down 81.0% YoY from $24.6 million in Q1 2025.

Analysis

Zymeworks (ZYME) Receivables - Net (2021 - 2026) Analysis & Trends

Zymeworks has reported Receivables - Net for 6 years, with the latest figure at $4.7 million in Q1 2026.

  • Quarterly Receivables - Net fell 81.0% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (down 81.0% YoY) and the FY2025 annual result came in at $4.6 million, down 91.69% from the prior year.
  • Receivables - Net improved to $4.7 million in Q1 2026 per ZYME's latest filing, from $4.6 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $67.3 million in Q3 2023 and troughed at $2.6 million in Q2 2025.
  • A 5-year average of $30.1 million and a median of $29.4 million in 2025 frame the typical range for Receivables - Net.
  • The sharpest annual moves came in 2023 and 2025: Receivables - Net surged 899.9% in 2023, then plunged 91.8% in 2025.
  • Over 5 years, Receivables - Net stood at $33.4 million in 2022, then plunged by 41.69% to $19.5 million in 2023, then surged by 186.57% to $55.8 million in 2024, then plunged by 91.69% to $4.6 million in 2025, then advanced by 0.78% to $4.7 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $4.7 million, $4.6 million, and $29.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.93 Mn
Mar 31, 2026 4.67 Mn
Dec 31, 2025 4.64 Mn
Sep 30, 2025 29.35 Mn
Jun 30, 2025 2.63 Mn
Mar 31, 2025 24.59 Mn
Dec 31, 2024 55.82 Mn
Sep 30, 2024 23.70 Mn
Jun 30, 2024 32.08 Mn
Mar 31, 2024 30.95 Mn
Dec 31, 2023 19.48 Mn
Sep 30, 2023 67.27 Mn
Jun 30, 2023 48.82 Mn
Mar 31, 2023 66.92 Mn
Dec 31, 2022 33.40 Mn
Sep 30, 2022 6.73 Mn
Dec 31, 2021 15.61 Mn